Drug recalls

Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77…

Houston Rx LLC · Lack of assurance of sterility.

Class IIOngoingD-0040-2027
Status
Ongoing
City
Houston
State
TX
Country
United States
Classification
Class II
Product type
Drugs
Event ID
99990
Recalling firm
Houston Rx LLC
Address 1
15340 Vantage Pkwy E Ste 220
Postal code
77032-1901
Voluntary mandated
Voluntary: Firm initiated
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Distribution pattern
Nationwide in the USA.
Recall number
D-0040-2027
Product description
Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.
Product quantity
64 vials
Reason for recall
Lack of assurance of sterility.
Recall initiation date
20260925
Center classification date
20261013
Report date
20261021
Code info
Lot# TZN-080326-20/2-2, Beyond Use Date: 12/01/2026.
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.